Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Contact form








 


Note! If you want an answer on a question you must specify your email address




Peter Bernhardt

Professor/ medical physicist

Peter Bernhardt
Professor/ medical physicist
peter.bernhardt@gu.se
+46 31-342 8509

Postal Address: Sahlgrenska universitetssjukhuset, 41345 Göteborg
Visiting Address: Jubileumskliniken, blå stråket 2 , 41345 Göteborg


Department of Radiation Physics at Institute of Clinical Sciences (More Information)
Sahlgrenska Universitetssjukhuset
413 45 Göteborg
Visiting Address: Gula stråket 2 B SU/Sahlgrenska , 413 45 Göteborg

Latest publications

Combination of Proton Therapy and Radionuclide Therapy in Mice: Preclinical Pilot Study at the Paul Scherrer Institute
C. Muller, M. D. Leal, M. D. Dominietto, C. A. Umbricht, S. Safai et al.
Pharmaceutics, Journal article 2019
Journal article

Therapeutic Potential of Sc-47 in Comparison to Lu-177 and Y-90: Preclinical Investigations
K. Siwowska, P. Guzik, K. A. Domnanich, J. M. M. Rodriguez, Peter Bernhardt et al.
Pharmaceutics, Journal article 2019
Journal article

Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
C. Muller, C. A. Umbricht, N. Gracheva, V. J. Tschan, G. Pellegrini et al.
European Journal of Nuclear Medicine and Molecular Imaging, Journal article 2019
Journal article

Establishment of Optimized SPECT/CT Protocol for Therapy with 161Tb Demonstrate Improved Image Quality with Monte Carlo Based OSEM Reconstruction
Ida Marin, Tobias Rydén, Martijn van Essen, Johanna Svensson, N. Van der Meulen et al.
31st Annual Congress of the EANM, Conference contribution 2018
Conference contribution

Feasibility of simplifying renal dosimetry in Lu-177 peptide receptor radionuclide therapy
A. Sundlov, J. Gustafsson, G. Brolin, N. Mortensen, Rebecka Hermann et al.
Ejnmmi Physics, Journal article 2018
Journal article

Showing 1 - 10 of 107

2019

Combination of Proton Therapy and Radionuclide Therapy in Mice: Preclinical Pilot Study at the Paul Scherrer Institute
C. Muller, M. D. Leal, M. D. Dominietto, C. A. Umbricht, S. Safai et al.
Pharmaceutics, Journal article 2019
Journal article

Therapeutic Potential of Sc-47 in Comparison to Lu-177 and Y-90: Preclinical Investigations
K. Siwowska, P. Guzik, K. A. Domnanich, J. M. M. Rodriguez, Peter Bernhardt et al.
Pharmaceutics, Journal article 2019
Journal article

Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
C. Muller, C. A. Umbricht, N. Gracheva, V. J. Tschan, G. Pellegrini et al.
European Journal of Nuclear Medicine and Molecular Imaging, Journal article 2019
Journal article

2018

Establishment of Optimized SPECT/CT Protocol for Therapy with 161Tb Demonstrate Improved Image Quality with Monte Carlo Based OSEM Reconstruction
Ida Marin, Tobias Rydén, Martijn van Essen, Johanna Svensson, N. Van der Meulen et al.
31st Annual Congress of the EANM, Conference contribution 2018
Conference contribution

Feasibility of simplifying renal dosimetry in Lu-177 peptide receptor radionuclide therapy
A. Sundlov, J. Gustafsson, G. Brolin, N. Mortensen, Rebecka Hermann et al.
Ejnmmi Physics, Journal article 2018
Journal article

Showing 1 - 10 of 107

Page Manager: Johan Spetz|Last update: 11/20/2013
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?